Cigna (CI) Q4 Preview: Key Information Before Earnings Release

Cigna Set to Announce Earnings: What Investors Should Know

Cigna (NYSE:CI), a major player in the health insurance industry, is scheduled to release its latest earnings report this Thursday before the market opens. Here’s a breakdown of what to keep an eye on.

In the previous quarter, Cigna surpassed Wall Street’s revenue projections by 3.1%, posting $69.57 billion in revenue—a 9.2% increase compared to the same period last year. The company delivered a solid performance, outpacing revenue forecasts, though its full-year earnings per share guidance matched analyst expectations. Cigna’s customer base declined by 3,000, ending the quarter with 16.35 million members.

Should You Buy or Sell Cigna Ahead of Earnings?

Curious about whether Cigna is a smart investment before its earnings release?

Analyst Expectations for This Quarter

For the upcoming quarter, analysts anticipate Cigna’s revenue will reach $69.86 billion, representing a 6.4% year-over-year increase—a slower pace compared to the 28.4% surge seen in the same quarter last year. Adjusted earnings per share are forecasted at $7.88.

Analyst Sentiment and Track Record

Over the past month, analysts have largely maintained their forecasts for Cigna, indicating confidence in the company’s current trajectory. Notably, Cigna has consistently outperformed revenue expectations for the past two years, averaging a 5% beat each quarter.

Industry Peers: Recent Results

Several of Cigna’s competitors in the healthcare providers and services sector have already released their fourth-quarter results, offering some context for Cigna’s upcoming report. UnitedHealth posted a 12.3% year-over-year revenue increase, aligning with analyst predictions, while Elevance Health saw a 9.6% rise in revenue but missed estimates by 1.2%. Following these announcements, UnitedHealth’s stock dropped 16.4%, whereas Elevance Health’s shares climbed 7.5%.

For a deeper dive, read our full breakdown of UnitedHealth’s performance here and Elevance Health’s results here.

Market Trends and Cigna’s Outlook

Investors in the healthcare providers and services space have remained relatively steady ahead of earnings, with the sector’s share prices dipping by an average of 1.7% over the past month. Cigna’s stock has declined 3.2% during this period. The average analyst price target for Cigna stands at $326.92, compared to its current price of $274.94.

Special Opportunity: Discover an Overlooked AI Stock

Don’t get caught up in the AI stocks everyone is talking about. The real opportunity may lie in a highly profitable AI company that’s still under the radar. We’ve uncovered an AI powerhouse that Wall Street hasn’t noticed yet. This research won’t be available forever—claim your free report before it’s gone. Get your copy here.